These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

681 related items for PubMed ID: 17763975

  • 1. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
    Woo SU, Bae JW, Kim CH, Lee JB, Koo BW.
    Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
    [Abstract] [Full Text] [Related]

  • 2. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [Abstract] [Full Text] [Related]

  • 3. Expression of CXCR4 is associated with axillary lymph node status in patients with early breast cancer.
    Su YC, Wu MT, Huang CJ, Hou MF, Yang SF, Chai CY.
    Breast; 2006 Aug; 15(4):533-9. PubMed ID: 16239110
    [Abstract] [Full Text] [Related]

  • 4. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer.
    Cabioglu N, Yazici MS, Arun B, Broglio KR, Hortobagyi GN, Price JE, Sahin A.
    Clin Cancer Res; 2005 Aug 15; 11(16):5686-93. PubMed ID: 16115904
    [Abstract] [Full Text] [Related]

  • 5. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Clin Cancer Res; 2003 Nov 01; 9(14):5313-7. PubMed ID: 14614015
    [Abstract] [Full Text] [Related]

  • 6. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R, Basik M.
    Breast Cancer Res Treat; 2006 Jun 01; 97(3):275-83. PubMed ID: 16344916
    [Abstract] [Full Text] [Related]

  • 7. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL.
    Cancer; 2003 Apr 15; 97(8):1841-8. PubMed ID: 12673709
    [Abstract] [Full Text] [Related]

  • 8. The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
    Ko SS, Na YS, Yoon CS, Park JY, Kim HS, Hur MH, Lee HK, Chun YK, Kang SS, Park BW, Lee JH.
    Int J Surg Pathol; 2007 Apr 15; 15(2):98-109. PubMed ID: 17478762
    [Abstract] [Full Text] [Related]

  • 9. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
    Fukunaga S, Maeda K, Noda E, Inoue T, Wada K, Hirakawa K.
    Oncology; 2006 Apr 15; 71(3-4):204-11. PubMed ID: 17641542
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN.
    Clin Cancer Res; 2005 May 01; 11(9):3315-9. PubMed ID: 15867229
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinicopathological correlation between expression of PTHrP receptor and various prognostic factors in breast cancer without axillary lymph node metastasis.
    Suzuki Y, Tokuda Y, Saito Y, Umemura S, Osamura RY.
    Tokai J Exp Clin Med; 2005 Jul 01; 30(2):127-32. PubMed ID: 16146204
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery.
    Greenberg R, Barnea Y, Schneebaum S, Kashtan H, Kaplan O, Skornik Y.
    Isr Med Assoc J; 2003 Sep 01; 5(9):649-52. PubMed ID: 14509156
    [Abstract] [Full Text] [Related]

  • 19. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
    Holm NT, Byrnes K, Li BD, Turnage RH, Abreo F, Mathis JM, Chu QD.
    J Surg Res; 2007 Jul 01; 141(1):53-9. PubMed ID: 17574038
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.